You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 27, 2024

CEFAZOLIN IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Cefazolin In Plastic Container patents expire, and what generic alternatives are available?

Cefazolin In Plastic Container is a drug marketed by Baxter Hlthcare Corp and is included in one NDA.

The generic ingredient in CEFAZOLIN IN PLASTIC CONTAINER is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cefazolin In Plastic Container

A generic version of CEFAZOLIN IN PLASTIC CONTAINER was approved as cefazolin sodium by SANDOZ on December 9th, 1988.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CEFAZOLIN IN PLASTIC CONTAINER?
  • What are the global sales for CEFAZOLIN IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for CEFAZOLIN IN PLASTIC CONTAINER?
Summary for CEFAZOLIN IN PLASTIC CONTAINER
Drug patent expirations by year for CEFAZOLIN IN PLASTIC CONTAINER
Recent Clinical Trials for CEFAZOLIN IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
St. Louis UniversityPhase 4
Abdul El-RabbanyPhase 4
Assistance Publique Hopitaux De MarseillePhase 4

See all CEFAZOLIN IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for CEFAZOLIN IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare Corp CEFAZOLIN IN PLASTIC CONTAINER cefazolin sodium SOLUTION;INTRAVENOUS 207131-002 Feb 1, 2021 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare Corp CEFAZOLIN IN PLASTIC CONTAINER cefazolin sodium SOLUTION;INTRAVENOUS 207131-001 Aug 7, 2015 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.